simendan has been researched along with pituitrin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Krum, H; Liew, D | 1 |
| Harjola, VP; Siirilä-Waris, K; Suojaranta-Ylinen, R | 1 |
| Buerke, M; Russ, M; Werdan, K | 1 |
| Bryant, SM; Espinoza, TR; Mottram, AR | 1 |
| Noori, S; Seri, I | 1 |
| Cataldi, L; Toth-Heyn, P | 1 |
| Li, Z; Liu, Y; Ma, S; Wang, X; Xu, W | 1 |
| Angelini, GD; Belletti, A; Benedetto, U; Biondi-Zoccai, G; Landoni, G; Leggieri, C; Silvani, P; Zangrillo, A | 1 |
| Kleinsasser, A; Knotzer, H; Kotzinger, O; Poidinger, B; Rützler, K; Zierer, A | 1 |
| Dempsey, E; Rabe, H | 1 |
| Gordon, A; McAuley, DF; O'Kane, C; Prevost, AT; Santhakumaran, S; Shankar-Hari, M | 1 |
| Axelsson, B; Grafver, I; Jansson, K; Kiszakiewicz, L; Nilsson, KF; Oikonomakis, I; Seilitz, J | 1 |
6 review(s) available for simendan and pituitrin
| Article | Year |
|---|---|
New and emerging drug therapies for the management of acute heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Heart Failure; Humans; Hydrazones; Natriuretic Agents; Natriuretic Peptide, Brain; Pyridazines; Pyridines; Simendan; Tetrazoles; Treatment Outcome; Vasodilator Agents; Vasopressins | 2003 |
[New pharmacological treatment approaches to cardiogenic shock].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cardiotonic Agents; Catecholamines; Complement C5; Complement Inactivating Agents; Humans; Hydrazones; Intra-Aortic Balloon Pumping; Myocardial Infarction; Myocardial Revascularization; Nitric Oxide Synthase; Pyridazines; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Simendan; Survival Rate; Vasopressins | 2007 |
Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
Topics: Cardiotonic Agents; Cardiovascular System; Dobutamine; Dopamine; Epinephrine; Hemodynamics; Humans; Hydrazones; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Milrinone; Pyridazines; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2012 |
Vasoactive compounds in the neonatal period.
Topics: Adrenal Cortex Hormones; Cardiovascular System; Catecholamines; Humans; Hydrazones; Hypotension; Infant, Newborn; Milrinone; Pyridazines; Simendan; Vasodilator Agents; Vasopressins | 2012 |
The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Topics: Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Hydrazones; Network Meta-Analysis; Norepinephrine; Odds Ratio; Pyridazines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2017 |
The Use of Cardiotonic Drugs in Neonates.
Topics: Adrenal Cortex Hormones; Asphyxia Neonatorum; Cardiotonic Agents; Dobutamine; Dopamine; Heart Defects, Congenital; Humans; Hypotension; Infant, Newborn; Intensive Care Units, Neonatal; Milrinone; Neonatal Sepsis; Norepinephrine; Persistent Fetal Circulation Syndrome; Shock; Simendan; Vasoconstrictor Agents; Vasopressins | 2019 |
1 trial(s) available for simendan and pituitrin
| Article | Year |
|---|---|
Levosimendan in cardiac surgery.
Topics: Aged; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Coronary Artery Disease; Epinephrine; Female; Follow-Up Studies; Hemodynamics; Humans; Hydrazones; Male; Milrinone; Norepinephrine; Postoperative Care; Preoperative Care; Pyridazines; Risk Factors; Simendan; Time Factors; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins; Ventricular Dysfunction, Left | 2005 |
5 other study(ies) available for simendan and pituitrin
| Article | Year |
|---|---|
Levosimendan for calcium channel blocker poisoning in humans.
Topics: Blood Pressure; Calcium Channel Blockers; Catecholamines; Hemodynamics; Humans; Hydrazones; Hyperinsulinism; Pyridazines; Simendan; Vasoconstriction; Vasodilator Agents; Vasopressins | 2009 |
Effects and mechanism analysis of combined infusion by levosimendan and vasopressin on acute lung injury in rats septic shock.
Topics: Acute Lung Injury; Animals; Blood Gas Analysis; Cardiovascular Agents; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Female; HMGB1 Protein; Hydrazones; Lung; Nitrogen Oxides; Norepinephrine; Pyridazines; Rats; Shock, Septic; Simendan; Vasopressins | 2014 |
Intravenous Levosimendan and Vasopressin in New-Onset Acute Pulmonary Hypertension After Weaning from Cardiopulmonary Bypass.
Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiopulmonary Bypass; Cardiotonic Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypertension, Pulmonary; Injections, Intravenous; Male; Retrospective Studies; Simendan; Treatment Outcome; Vascular Resistance; Vasoconstrictor Agents; Vasopressins | 2019 |
Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials.
Topics: Adult; Aged; Anti-Inflammatory Agents; APACHE; Cardiotonic Agents; Critical Illness; Female; Guideline Adherence; Hospital Mortality; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intensive Care Units; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Sepsis; Simendan; Simvastatin; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2019 |
A Randomized Porcine Study in Low Cardiac Output of Vasoactive and Inotropic Drug Effects on the Gastrointestinal Tract.
Topics: Animals; Cardiac Output, Low; Disease Models, Animal; Female; Gastrointestinal Tract; Male; Milrinone; Norepinephrine; Random Allocation; Simendan; Splanchnic Circulation; Swine; Vasodilator Agents; Vasopressins | 2021 |